Hypersensitivity: Edema (facial edema, palpebral edema), facial flare, rare rash, urticaria and itching may occur. In the occurrence of adverse reaction, the drug is discontinued and appropriate measures are taken.
Injection site: Occasional pain (transient pain after administration), swelling, rare hydrops, flare, warmth, severe compressing sense on local site and ecchymosis may occur.
Others: Nausea, vomiting, fever and headache may occur.
View ADR Monitoring Form